Oxfam America
Already advocating as a shareholder
Files shareholder resolutions in its own name. It has filed at 9 companies, among them AbbVie and Pfizer Inc. in 2022.
Issues this organization works on
Offers fair pricing, Pays a fair, living wage, Protects worker health and safety
How Oxfam America publishes its voting positions
Not yet researched. That means we have not checked, not that nothing is published.
Companies Oxfam America has engaged as a shareholder
7 recorded campaigns across 3 companies.
Oxfam America at Chevron, ExxonMobil, ConocoPhillips, Kosmos Energy
Publicly report earnings and taxes in every country of operation using Global Reporting Initiative standards.
Oxfam America at ConocoPhillips, Chevron and ExxonMobil
Improve disclosure, including public country-by-country reporting of revenue, profit and tax, to prevent tax avoidance.
Oxfam America and the Missionary Oblates of Mary Immaculate at ExxonMobil, Chevron, ConocoPhillips and Amazon
Asked each company to issue a tax transparency report to shareholders, at reasonable expense and excluding confidential information, prepared in consideration of the indicators and guidelines in the Global Reporting Initiative's Tax Standard, which includes public country-by-country reporting of revenues, profits and taxes paid in each jurisdiction.
Oxfam America at Moderna, Pfizer and Johnson & Johnson on COVID-19 vaccine access
At Moderna and Pfizer, asked the board to commission a third-party report analysing the feasibility of promptly transferring intellectual property and technical know-how so that additional qualified manufacturers in low and middle income countries could produce COVID-19 vaccine doses. At Johnson & Johnson, asked the board to report on whether and how its subsidiary Janssen's receipt of government financial support for developing and manufacturing vaccines and therapeutics affected access to them.
Oxfam America at Pfizer
Study the feasibility of transferring vaccine technology and know-how to ramp up production and improve sustainable access to its COVID-19 vaccine worldwide.
Oxfam America at Moderna
Study the feasibility of sharing Moderna's mRNA COVID-19 vaccine technology and know-how with resource-poor countries to expand global manufacturing and access.
Oxfam America at Johnson & Johnson
Report on whether and how government financial support is being or will be considered in developing the company's access strategies for COVID-19 vaccines and therapeutics, including pricing.
Do you work at Oxfam America? Claim this profile to add campaigns and publish how you recommend voting.
